Dr. Charles Lynde

Dermatologist, Markham, ON

Dr. Charles Lynde is an Associate Professor in the Department of Medicine at the University of Toronto and holds a clinical teaching position at the University Health Network. He is the Medical Director of Lynde Institute for Dermatology and Lynderm Research. The Lynde Institute for Dermatology is a full service, interdisciplinary dermatology clinic. After receiving his B.Sc. and MD, degrees at the University of Toronto, Dr. Lynde studied Dermatology at the University of British Columbia and the University of Toronto, receiving his Board Certification (Canada and USA) in 1983.

Lynderm Research is under the guidance of Dr. Lynde as principal investigator for more than 30 years and over 300 clinical trials and is actively involved in the management of psoriasis, rosacea, onychomycosis, acne and atopic dermatitis among other dermatological conditions. Dr. Lynde has authored over 200 peer-reviewed articles.

Dr. Lynde has served in various roles for the CDA and AAD, including President of the Canadian Dermatology Association. He is the Editor of the CDA eBulletin and sits on the editorial boards of several journals and provides extensive consulting as well as being on the advisory boards of many pharmaceutical companies. Dr. Lynde is a frequent guest speaker both nationally and internationally at various dermatological conferences. Recognizing the need for external education he is committed to the training of new and current healthcare professionals in his community and residents through the university program.

3:20 PM - 4:20 PM

FRI Apr 28

The Role of Skin Care in Cancer Therapy-Related Cutaneous Adverse Events for Cancer Patients and Survivors

The CaSMO project aims to improve the quality of life for cancer patients and survivors by offering tools to prevent and manage cutaneous adverse events. These tools aim to support all healthcare providers treating oncology patients, including physicians, nurses, pharmacists, and advanced providers. In this one-hour session, our faculty will review these tools developed to manage skin-related toxicities for cancer patients undergoing radiation, immunotherapy, hormonal therapy, and targeted therapies.

1:55 PM - 2:25 PM

SAT Apr 29

A multicenter evaluation of a ceramide-containing hydrating cream-to-foam cleanser and facial moisturizing lotion for improving acne treatment tolerability and adherence

Evaluate the impact of a ceramide-containing hydrating cream-to-foam cleanser and PM facial moisturizing lotion on acne treatment tolerability and adherence.

Present and discuss the multicenter, open-label, cohort study of a topical retinoid and daily use of an adjunct cleanser and moisturizer to prevent adverse events and improve compliance with prescription acne treatments.

3:25 PM - 3:55 PM

SAT Apr 29

JAK Inhibition: What It All Really Means

7:00 AM - 11:00 AM

SUN Apr 30

Pfizer Medical Advisory Board